The first generic version of Cuvposa® (glycopyrrolate) Oral Solution has been made available by Endo International.
Glycopyrrolate Oral Solution is an anticholinergic indicated to reduce chronic severe drooling in patients 3 to 16 years of age with neurologic conditions associated with problem drooling (eg, cerebral palsy).
The generic product is supplied as 1mg of glycopyrrolate per 5mL in a 16oz bottle. Glycopyrrolate Oral Solution should be measured and administered with an accurate measuring device.
Continue Reading
Par Pharmaceutical has begun shipping the product in the US.
Reference
Endo launches first generic version of Cuvposa® (glycopyrrolate) Oral Solution. News release. Endo International plc. January 4, 2022. Accessed January 5, 2022. https://www.prnewswire.com/news-releases/endo-launches-first-generic-version-of-cuvposa-glycopyrrolate-oral-solution-301454073.html.
This article originally appeared on MPR
